KDM5D (Lysine Demethylase 5D), also known as JARID1D or SMCY (Smcy homolog), is a JmjC domain-containing histone demethylase that specifically removes methyl groups from histone H3 lysine 4 (H3K4). [@christensen2007] As a member of the KDM5 family (also known as JARID1 family), KDM5D plays important roles in gene regulation, spermatogenesis, and has emerging implications for cognitive function and potential roles in neurodegeneration. [@maze2010]
Unlike its paralogs KDM5A, KDM5B, and KDM5C which are widely expressed, KDM5D is primarily expressed in testis and has been studied most extensively in the context of male germ cell development and cancer. [@kim2014] However, recent research has begun to uncover potential roles for KDM5 family members in neuronal function and epigenetic regulation in the brain, with implications for Alzheimer's disease and other neurodegenerative disorders. [@liu2020]
| Property | Value | Reference |
|---|---|---|
| Gene Symbol | KDM5D | |
| Full Name | Lysine Demethylase 5D | |
| Alternative Names | JARID1D, SMCY | |
| Chromosomal Location | Yq11.223 (Y chromosome) | |
| NCBI Gene ID | 56843 | |
| OMIM | 426000024 | |
| Ensembl ID | ENSG00000125675 | |
| UniProt ID | Q9Y2T7 |
KDM5D is a large nuclear protein (~1560 amino acids) with multiple functional domains that enable its role in chromatin regulation:
JmjN Domain: Located at the N-terminus, this domain works cooperatively with the JmjC domain and is essential for demethylase activity. While structurally important, the JmjN domain lacks catalytic activity on its own. [@klose2007]
JmjC Domain: The central catalytic domain that coordinates the Fe²⁺ and 2-oxoglutarate (2-OG) cofactors required for demethylation. This domain mediates the removal of methyl groups from H3K4me2 and H3K4me3 marks. [@christensen2007]
ARID Domain (AT-rich Interactive Domain): A DNA-binding domain that recognizes and binds to specific DNA sequences, enabling target gene specificity. The ARID domain facilitates recruitment of KDM5D to specific genomic loci.
C5HC2-type Zinc Fingers: Multiple zinc finger motifs throughout the protein that mediate protein-protein interactions and chromatin binding.
PLU-1 Domain: Named after the founding member (PLU-1/KDM5B), this region is involved in transcriptional repression.
The overall architecture of KDM5D allows it to:
KDM5D's primary biological function is in male germ cell development:
Spermatogonia Proliferation: During early spermatogenesis, KDM5D helps regulate the transcriptional program necessary for proliferation of spermatogonial stem cells. [@ito2015]
Meiotic Progression: KDM5D is required for proper progression through meiosis, particularly during the transition from spermatocytes to round spermatids.
Spermatid Differentiation: In post-meiotic spermatids, KDM5D regulates genes necessary for sperm head formation and the extensive chromatin remodeling that occurs during spermiogenesis. [@winters2011]
X-Chromosome Inactivation Escape: As a Y-linked gene, KDM5D provides important epigenetic regulation that complements X-linked genes, ensuring proper gene expression in males.
As an H3K4 demethylase, KDM5D functions as a transcriptional repressor:
H3K4 Demethylation: KDM5D removes the activating H3K4me3 mark from promoter regions, leading to transcriptional silencing of target genes. [@kim2014]
Chromatin State Modulation: By dynamically regulating H3K4 methylation, KDM5D contributes to the establishment and maintenance of specific chromatin states during development and cell differentiation.
Developmental Gene Expression: During embryogenesis and tissue differentiation, KDM5D helps orchestrate the precise timing of gene expression by removing inappropriate H3K4 methylation marks.
While KDM5D itself has limited expression in the brain, the KDM5 family (particularly KDM5A, KDM5B, and KDM5C) plays important roles in neuronal function:
Cognitive Function: The KDM5 family regulates genes critical for learning and memory. Altered KDM5 expression or activity can affect cognitive performance. [@catchpole2011]
Neuronal Development: During brain development, KDM5 demethylases help establish appropriate gene expression patterns in neural precursor cells. [@huang2021]
Synaptic Plasticity: Activity-dependent changes in H3K4 methylation at synaptic genes are mediated in part by KDM5 family members, affecting long-term potentiation (LTP) and memory formation.
Epigenetic Memory: The dynamic nature of H3K4 methylation, regulated by methyltransferases and demethylases like KDM5, provides a mechanism for epigenetic memory in neurons.
| Tissue | Expression Level | Notes |
|---|---|---|
| Testis | High | Primary site of expression; essential for spermatogenesis |
| Spleen | Low-Moderate | Limited immune cell expression |
| Brain | Very Low | Limited neuronal expression; KDM5C more relevant |
| Other tissues | Minimal | Low or undetectable |
While KDM5D is not classically considered an Alzheimer's disease gene, the KDM5 family has emerging connections to AD pathophysiology:
Epigenetic Dysregulation: Alzheimer's disease is associated with widespread epigenetic changes, including alterations in histone methylation. [@liu2020] Dysregulation of H3K4 methylation has been documented in AD brains.
Gene Expression Changes: Altered expression of KDM5 family members has been observed in AD brain tissue, potentially contributing to the dysregulated transcription seen in neurodegeneration.
Cognitive Impairment: Given the role of KDM5 family members in cognitive function, pharmacological modulation of KDM5 activity represents a potential therapeutic approach for AD-related cognitive decline. [@xu2022]
Neuroinflammation: Recent work on KDM5C in T cell-driven autoimmunity suggests potential immune-related mechanisms that could intersect with neuroinflammation in AD. [@fazazi2023]
KDM5D has more well-established roles in cancer:
Prostate Cancer: KDM5D is often downregulated in prostate cancer and functions as a tumor suppressor. Loss of KDM5D expression is associated with more aggressive disease.
Testicular Cancer: High KDM5D expression in germ cell tumors reflects its normal role in male germ cells.
Other Cancers: Variable expression patterns in breast, bladder, and other cancers, with context-dependent tumor suppressor or oncogenic functions.
Male Factor Infertility: As expected from its essential role in spermatogenesis, KDM5D mutations are associated with male factor infertility. [@winters2011]
X-linked Disorders: The KDM5 family (particularly X-linked KDM5C) is associated with X-linked intellectual disability and autism spectrum disorders. While KDM5D itself is Y-linked, it may provide complementary function.
Neurodevelopmental Implications: Altered KDM5 activity during brain development could potentially affect cognitive outcomes, though this is more relevant for KDM5C than KDM5D.
The broader KDM5 family has more established connections to neurodegeneration:
Histone Demethylase Inhibition: Small molecule inhibitors targeting KDM5 demethylases are being developed for various applications. [@rusche2022]
Cognitive Enhancement: Modulation of KDM5 activity could enhance cognitive function by altering the epigenetic landscape at memory-related genes.
Neuronal Survival: KDM5-mediated epigenetic regulation influences neuronal survival pathways relevant to neurodegeneration.
Prenatal Exposure: A recent study showed that prenatal arsenic exposure causes cognitive dysfunction through KDM5-regulated reprogramming of autophagy in the developing brain. [@wang2024] This demonstrates a direct link between KDM5 activity and cognitive outcomes.
Autoimmunity: KDM5C's role in T cell-driven autoimmunity in the CNS suggests broader implications for neuroimmune interactions. [@fazazi2023]
Therapeutic Potential: Targeting KDM5 enzymes represents a novel approach to treating neurodegenerative diseases by modulating the epigenetic landscape. [@xu2022]
The KDM5 family is an emerging drug target:
| Compound | Target | Stage | Notes |
|---|---|---|---|
| CPI-455 | KDM5 family | Preclinical | First-generation inhibitor |
| KDM5-C70 | KDM5A/B | Research | Cell-permeable |
| KDOAM-25 | KDM5A | Research | Used in cancer studies |
| Novel bifunctional degraders | KDM5 family | Early development | Targeted protein degradation |
Brain Penetration: Achieving sufficient brain penetration for CNS applications remains challenging.
Selectivity: Developing selective inhibitors for specific KDM5 family members is difficult due to high structural similarity.
Dosage Effects: The biphasic nature of H3K4 methylation (both methylation and demethylation are necessary) requires careful dosing considerations.
Sex-Specific Effects: As a Y-chromosome gene, KDM5D has inherently sex-specific expression, limiting therapeutic applications to males.